Brandinium

Trademark search for:

PHLOGENZYM

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2006-12-18 — Application filed
  • 2006-12-21 — Application filed
  • 2007-02-19 — Teas change of correspondence received
  • 2007-04-11 — Final disposition recorded
  • 2007-04-11 — Assigned to examiner
  • 2007-04-12 — Final disposition recorded
  • 2007-06-04 — Teas change of correspondence received
  • 2007-10-11 — Fax received
  • 2007-10-11 — Fax received
  • 2007-11-08 — Amendment from applicant entered
  • 2007-11-08 — Assigned to lie
  • 2007-11-08 — Correspondence received in law office
  • 2007-11-26 — Examiners amendment mailed
  • 2007-11-26 — Examiners amendment -written
  • 2007-11-26 — Teas/email correspondence entered
  • 2007-11-26 — Office action issued
  • 2007-11-26 — Examiner's amendment entered
  • 2007-11-26 — Correspondence received in law office
  • 2007-11-27 — Approved for pub - principal register
  • 2007-11-27 — Law office publication review completed
  • 2007-12-12 — Notice of publication
  • 2008-01-01 — Published for opposition
  • 2008-03-25 — Noa mailed - sou required from applicant
  • 2008-09-24 — Sou teas extension received
  • 2008-09-24 — Sou extension 1 filed
  • 2008-09-24 — Sou extension 1 granted
  • 2009-03-24 — Sou teas extension received
  • 2009-03-24 — Sou extension 2 filed
  • 2009-04-07 — Case assigned to intent to use paralegal
  • 2009-04-07 — Sou extension 2 granted
  • 2009-09-25 — Sou teas extension received
  • 2009-09-25 — Sou extension 3 filed
  • 2009-09-29 — Sou extension 3 granted
  • 2010-03-16 — Sou teas extension received
  • 2010-03-16 — Sou extension 4 filed
  • 2010-03-23 — Sou extension 4 granted
  • 2010-03-24 — Notice of approval of extension request e-mailed
  • 2010-09-22 — Sou teas extension received
  • 2010-09-22 — Sou extension 5 filed
  • 2010-09-26 — Sou extension 5 granted
  • 2010-09-28 — Notice of approval of extension request e-mailed
  • 2011-03-09 — Teas statement of use received
  • 2011-03-09 — Use amendment filed
  • 2011-03-11 — Statement of use processing complete
  • 2011-03-14 — Final disposition recorded
  • 2011-03-14 — Final disposition recorded
  • 2011-03-14 — Final disposition recorded
  • 2011-09-07 — Office action issued
  • 2011-09-07 — Office action issued
  • 2011-09-09 — Assigned to lie
  • 2011-09-19 — Allowed principal register - sou accepted
  • 2011-09-19 — Teas/email correspondence entered
  • 2011-09-19 — Correspondence received in law office
  • 2011-09-23 — Law office registration review completed
  • 2011-09-24 — Notice of acceptance of statement of use e-mailed
  • 2011-11-01 — Registered-principal register
  • 2016-11-01 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2018-06-08 — Cancelled sec. 8 (6-yr)
  • 2018-06-08 — Final status recorded

Owner Information

MUCOS Pharma GmbH & Co. KG
Berlin DE
MUCOS Pharma GmbH & Co. KG
Berlin DE
MUCOS Pharma GmbH & Co. KG
Berlin DE

Correspondent

Joyce von Natzmer PEQUIGNOT + MYERS LLC
200 MADISON AVE., SUITE 1901
NEW YORK, NY 10016
UNITED STATES

Filing Details

Filing Date:
2006-12-18
Status Date:
2018-06-08
Category:
Pharmaceuticals
Filing Year:
1991

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.